Pinfold Medical Limited 10808341 true 2023-07-01 2024-06-30 2024-06-30 The principal activity of the company is that of general medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true Dr R W Harrison Mrs C M Harrison-Bevan 10808341 2023-07-01 2024-06-30 10808341 2024-06-30 10808341 bus:OrdinaryShareClass1 2024-06-30 10808341 core:RetainedEarningsAccumulatedLosses 2024-06-30 10808341 core:ShareCapital 2024-06-30 10808341 core:CurrentFinancialInstruments 2024-06-30 10808341 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 10808341 core:FurnitureFittingsToolsEquipment 2024-06-30 10808341 bus:FRS102 2023-07-01 2024-06-30 10808341 bus:AuditExempt-NoAccountantsReport 2023-07-01 2024-06-30 10808341 bus:FullAccounts 2023-07-01 2024-06-30 10808341 bus:RegisteredOffice 2023-07-01 2024-06-30 10808341 bus:Director1 2023-07-01 2024-06-30 10808341 bus:Director2 2023-07-01 2024-06-30 10808341 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 10808341 bus:EntityNoLongerTradingButTradedInPast 2023-07-01 2024-06-30 10808341 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 10808341 countries:England 2023-07-01 2024-06-30 10808341 2023-06-30 10808341 core:FurnitureFittingsToolsEquipment 2023-06-30 10808341 2023-06-30 10808341 bus:OrdinaryShareClass1 2023-06-30 10808341 core:RetainedEarningsAccumulatedLosses 2023-06-30 10808341 core:ShareCapital 2023-06-30 10808341 core:CurrentFinancialInstruments 2023-06-30 10808341 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10808341

Pinfold Medical Limited

Annual Report and Unaudited Financial Statements

for the Year Ended 30 June 2024

 

Pinfold Medical Limited

Profit and Loss Account for the Year Ended 30 June 2024

The company has not traded during the year. During this year, the company received no income and incurred no expenditure and therefore made neither profit nor loss.

 

Pinfold Medical Limited

(Registration number: 10808341)
Balance Sheet as at 30 June 2024

Note

2024
£

2023
£

Current assets

 

Debtors

4

5,731

5,499

Cash at bank and in hand

 

83

83

 

5,814

5,582

Creditors: Amounts falling due within one year

6

(25,325)

(25,093)

Net liabilities

 

(19,511)

(19,511)

Capital and reserves

 

Called up share capital

7

2

2

Retained earnings

(19,513)

(19,513)

Shareholders' deficit

 

(19,511)

(19,511)

For the financial year ending 30 June 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and FRS 102 ‘The Financial Reporting Standard Applicable in the UK and Republic of Ireland’.

Approved and authorised by the Board on 11 March 2025 and signed on its behalf by:
 

.........................................
Dr R W Harrison
Director

 

Pinfold Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Springfield House Jackson Lane
Newton Upon Derwent
York
YO41 4ED
England

These financial statements were authorised for issue by the Board on 11 March 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Pinfold Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

 

Pinfold Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

3

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 July 2023

184

184

At 30 June 2024

184

184

Depreciation

At 1 July 2023

184

184

At 30 June 2024

184

184

Carrying amount

At 30 June 2024

-

-

4

Debtors

Current

2024
£

2023
£

Trade debtors

5,348

5,348

Prepayments

383

151

 

5,731

5,499

5

Cash and cash equivalents

2024
£

2023
£

Cash at bank

83

83

6

Creditors

Note

2024
£

2023
£

Due within one year

 

Trade creditors

 

10,000

10,000

Amounts due to related parties

15,093

14,943

Accruals

 

232

150

 

25,325

25,093

 

Pinfold Medical Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

7

Share capital

Allotted, called up and fully paid shares

2024

2023

No.

£

No.

£

Ordinary of £1 each

2

2

2

2